Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111975512 | 11197551 | 2 | F | 20160826 | 20150617 | 20160902 | PER | US-GLAXOSMITHKLINE-US2013000159 | GLAXOSMITHKLINE | 0.00 | F | Y | 52.15000 | KG | 20160902 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111975512 | 11197551 | 1 | SS | Ambrisentan Tablet | AMBRISENTAN | 1 | Unknown | 5 MG, QD | HMSH | 0 | 5 | MG | TABLET | QD | |||||
| 111975512 | 11197551 | 2 | PS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Unknown | 50 ML, QD | 20444 | 50 | ML | QD | |||||||
| 111975512 | 11197551 | 3 | SS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 80 MG, TID | R061117 | 0 | 80 | MG | TID | ||||||
| 111975512 | 11197551 | 4 | SS | VIAGRA | SILDENAFIL CITRATE | 1 | Unknown | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 111975512 | 11197551 | 5 | C | COUMADIN | WARFARIN SODIUM | 1 | UNK | U | 0 | ||||||||||
| 111975512 | 11197551 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 40 MG, QD | U | 0 | 40 | MG | QD | |||||||
| 111975512 | 11197551 | 7 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 20 UNK, UNK | U | 0 | 20 | MG | ||||||||
| 111975512 | 11197551 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 100 MG, QD | U | 0 | 100 | MG | QD | |||||||
| 111975512 | 11197551 | 9 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 75 UG, QD | U | 0 | 75 | UG | QD | |||||||
| 111975512 | 11197551 | 10 | C | DIGOXIN. | DIGOXIN | 1 | 125 UG, QD | U | 0 | 125 | UG | QD | |||||||
| 111975512 | 11197551 | 11 | C | ADCIRCA | TADALAFIL | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111975512 | 11197551 | 1 | Pulmonary arterial hypertension |
| 111975512 | 11197551 | 2 | Pulmonary arterial hypertension |
| 111975512 | 11197551 | 3 | Pulmonary arterial hypertension |
| 111975512 | 11197551 | 4 | Pulmonary arterial hypertension |
| 111975512 | 11197551 | 6 | Pulmonary arterial hypertension |
| 111975512 | 11197551 | 8 | Pulmonary arterial hypertension |
| 111975512 | 11197551 | 10 | Pulmonary arterial hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111975512 | 11197551 | Anaemia | |
| 111975512 | 11197551 | Diarrhoea | |
| 111975512 | 11197551 | Joint swelling | |
| 111975512 | 11197551 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111975512 | 11197551 | 1 | 20080220 | 0 | ||
| 111975512 | 11197551 | 2 | 19950406 | 0 | ||
| 111975512 | 11197551 | 3 | 2011 | 0 | ||
| 111975512 | 11197551 | 5 | 201503 | 0 |